21 insiders have filed at CON since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Ortenzio Robert A | Director | 8.17M | 6.357% | none | none |
| Newton William Keith | Chief Executive Officer | 482.8k | 0.376% | none | none |
| Dicanio Matthew T. | See Remarks | 342.3k | 0.266% | none | none |
| Mcandrew Douglas R. | See Remarks | 114.1k | 0.089% | none | none |
| Ryan Timothy F. | See Remarks | 114.1k | 0.089% | none | none |
| Gilbert Greg M. | See Remarks | 114.1k | 0.089% | none | none |
| Devasia Thomas A. | See Remarks | 114.1k | 0.089% | none | none |
| Conser Jonathan P. | See Remarks | 114.1k | 0.089% | none | none |
| Nelson Su Zan | See Remarks | 114.1k | 0.089% | none | none |
| Delorimier John A. | See Remarks | 113.6k | 0.088% | none | none |
| Kosuth Michael A. | See Remarks | 113.6k | 0.088% | none | none |
| Anderson John Robert JR. | See Remarks | 113.5k | 0.088% | none | none |
| Gallara Giovanni | See Remarks | 113.4k | 0.088% | none | none |
| Rhine Michael D. | See Remarks | 76.2k | 0.059% | none | none |
| Kendall Danielle | See Remarks | 76.1k | 0.059% | none | none |
| Thomas Daniel | Director | 74.0k | 0.058% | none | none |
| Pegus Cheryl | Director | 20.7k | 0.016% | none | none |
| Watkins Marc R. | Director | 20.7k | 0.016% | none | none |
| Gopal Vipin | Director | 15.5k | 0.012% | none | none |
| Bonner Brigid A. | Director | 15.5k | 0.012% | none | none |
| Select Medical Corp | 10% owner | none | none |
No open-market buys or sells have been reported at CON since 2023Q3. The table shows the filed stakes; it updates when an insider files.
Full register at boothcheck.com/insiders/CON. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.